Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON20790
NL-OMON20790
Recruiting
N/A

An explorative intervention study to investigate the feasibility and safety of oral immunotherapy with different allergens in young children diagnosed with food allergy.

Deventer Ziekenhuis0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Deventer Ziekenhuis
Enrollment
60
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Children with an age of 9 to 24 months.
  • •A proven food allergy (positive provocation and sensitization demonstrated by a skin prick test \> 3mm and / or slgÉ\> 0\.35kU / L) for chicken egg, peanut, cashew nut, hazelnut and / or wheat.
  • •Assessment of the presence of other food allergies (Standard care) by introduction in the diet and / or the determination of sensitization. From the mentioned allergens. Introduction into the diet or the diagnosis food
  • •allergy has been made.
  • •Written permission (signed informed consent form) from both parents / guardian for participation in the study.

Exclusion Criteria

  • •Uncontrolled viral wheezing, defined as admitted to hospital \> 1x in the past six months because of these complaints.
  • •Uncontrolled eczema.
  • •Severe gastrointestinal complaints such as gastroesophageal reflux disease, where an underlying disease such as eosinophilic esophagitis (EoE) cannot be excluded.
  • •Active EoE.
  • •Mastocytosis (also cutaneous).
  • •Psycho\-social problems in the family that may be a barrier to a good daily performance of long\-term therapy.
  • •Inability of parents to follow instructions, to recognize allergic reactions or to administer emergency medication.
  • •Participation in any other intervention study at the time of the ORKA study, with the exception of studies on guided early introduction of high\-allergenic nutrition.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
An explorative intervention study to investigate the feasibility and safety of oral immunotherapy with different allergens in young children diagnosed with food allergy.Food allergy10001708
NL-OMON49735Deventer Ziekenhuis240
Recruiting
N/A
An Exploratory Intervention Study to Evaluate the Improvement of Psychological Stress in Families of Adolescents with hikikomori by Telemedicine ConsultatioPsychological stress in families of adolescents with hikikomori
JPRN-UMIN000048187Yokohama City University40
Recruiting
Phase 2
An exploratory intervention study of renal rehabilitation for patients with conservative chronic kidney diseasechronic kidney diseaseproteinuriaD051436
JPRN-jRCT1030220165Aizawa Masashi12
Completed
N/A
on-interventional study to the investigation of the quality of life in patients on Politrate DepotC61Malignant neoplasm of prostate
DRKS00009594ribosepharm division Hikma Pharma GmbH907
Recruiting
Phase 1
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065Therapeutic area: Diseases [C] - Neoplasms [C04]Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
CTIS2024-510837-16-00Institut Gustave Roussy40